1. Home
  2. YMM vs BIO Comparison

YMM vs BIO Comparison

Compare YMM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YMM

Full Truck Alliance Co. Ltd. (each representing 20)

HOLD

Current Price

$11.22

Market Cap

11.6B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$301.03

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMM
BIO
Founded
2011
1952
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.6B
8.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
YMM
BIO
Price
$11.22
$301.03
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$12.67
$358.50
AVG Volume (30 Days)
6.8M
173.1K
Earning Date
11-17-2025
02-12-2026
Dividend Yield
1.72%
N/A
EPS Growth
29.34
N/A
EPS
0.53
N/A
Revenue
$1,751,813,549.00
$2,557,500,000.00
Revenue This Year
$11.64
$1.77
Revenue Next Year
$8.97
$2.30
P/E Ratio
$21.29
N/A
Revenue Growth
19.09
N/A
52 Week Low
$9.45
$211.43
52 Week High
$14.07
$373.69

Technical Indicators

Market Signals
Indicator
YMM
BIO
Relative Strength Index (RSI) 43.50 41.67
Support Level $11.10 $295.01
Resistance Level $11.53 $307.07
Average True Range (ATR) 0.28 8.47
MACD 0.02 -1.47
Stochastic Oscillator 12.80 20.90

Price Performance

Historical Comparison
YMM
BIO

About YMM Full Truck Alliance Co. Ltd. (each representing 20)

Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: